[Form 4] Celanese Corporation Insider Trading Activity

Rhea-AI Filing Summary

Deborah J. Kissire, a director of Celanese Corporation (CE), reported an acquisition of phantom stock on 08/11/2025 under the companys 2008 Deferred Compensation Plan. Each phantom share represents the right to receive one share of Celanese common stock. The filing lists 5,916.748 underlying shares and shows a referenced price of $47.42. The phantom shares represent dividend equivalents on compensation deferred under the Plan and become payable in common stock following the termination of Kissires service as a director.

The Form 4 was signed by an attorney-in-fact on 08/13/2025. The transaction is coded as an acquisition (A) of phantom stock rather than a sale or open-market trade, and the reporting person is identified as a director of the issuer.

Insights

Corporate Governance Expert

TL;DR: Routine director compensation deferral; no immediate sale or dilution reported.

The filing documents an acquisition of phantom stock representing dividend equivalents under Celaneses 2008 Deferred Compensation Plan. Such awards are common for non-employee directors and are payable in shares upon termination of service. The report specifies 5,916.748 underlying shares and a reference price of $47.42, and it is coded as an acquisition. From a governance perspective this appears to be a standard deferred-compensation transaction rather than an operational or governance red flag. The use of an attorney-in-fact to file is procedural and the disclosure follows required Section 16 reporting.

Compensation Analyst

TL;DR: Director received deferred dividend-equivalent phantom shares; payout contingent on future termination.

The Form 4 clarifies that each phantom share equals one common share and that the reported units are dividend equivalents under the 2008 Deferred Compensation Plan, payable in shares after the director leaves service. The reported quantity is 5,916.748 underlying common shares. Because these units are not immediate cash or open-market sales, the transaction primarily reflects compensation timing and vesting mechanics rather than a liquidity event. This is a compensation structure detail investors may note when modeling future potential dilution tied to long-term deferred awards.

08/13/2025 - 04:24 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kissire Deborah J.

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W LAS COLINAS BLVD, SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	08/11/2025		A		3.74		(2)	(2)	Common Stock	3.74	$47.42	5,916.748	D

Explanation of Responses:

1. Each share of phantom stock represents the right to receive one share of Common Stock.

2. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Deborah J. Kissire	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Deborah J. Kissire report on the Form 4 for Celanese (CE)?

The Form 4 reports an acquisition of phantom stock on 08/11/2025 under Celaneses 2008 Deferred Compensation Plan, representing 5,916.748 underlying common shares.

What is the nature of the phantom stock reported in the CE Form 4?

Each phantom share represents the right to receive one share of common stock and the reported units are dividend equivalents on deferred compensation payable in shares following termination.

Was the transaction an acquisition or a disposition in the CE filing?

The transaction is coded as an acquisition (A) of phantom stock, not a sale or disposition.

How many underlying shares and what price are shown in the filing?

The filing shows 5,916.748 underlying common shares and a referenced price of $47.42.

Who filed and signed the Form 4 for Deborah J. Kissire?

The form was signed by Christine Dryden, Attorney-in-Fact for Deborah J. Kissire on 08/13/2025.